Invivyd (IVVD) Prepaid Assets (2020 - 2026)
Invivyd's (IVVD) quarterly Prepaid Assets came in at $10.8 million in Q2 2026, down 31.05% on a YoY basis from $15.7 million in Q2 2025, and up 57.6% quarter-over-quarter from $6.9 million in Q4 2025.
Analysis
Invivyd (IVVD) Prepaid Assets (2020 - 2026) Analysis & Trends
Invivyd (IVVD) has reported Prepaid Assets for 7 consecutive years, with $10.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Prepaid Assets fell 31.05% year-over-year to $10.8 million; the trailing twelve-month figure through Jun 2026 stood at $10.8 million (down 31.05% YoY), and the FY2025 full-year result was $6.9 million, down 66.42% from the prior year.
- Prepaid Assets improved to $10.8 million in Q2 2026 per IVVD's latest filing, from $6.9 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $24.2 million in Q4 2023 and bottomed at $2.9 million in Q3 2022.
- Historically, Prepaid Assets has averaged $13.1 million across 5 years, with a median of $11.6 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets sank 80.52% in 2022, then surged 392.08% in 2023.
- Over 5 years, Prepaid Assets stood at $4.9 million in 2022, then soared by 392.08% to $24.2 million in 2023, then slipped by 15.73% to $20.4 million in 2024, then plunged by 66.42% to $6.9 million in 2025, then jumped by 57.6% to $10.8 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $10.8 million, $6.9 million, and $15.0 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Invivyd | 244.65 Mn | 84.57 Mn | 13.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.81 Mn |
| Dec 31, 2025 | 6.86 Mn |
| Sep 30, 2025 | 14.95 Mn |
| Jun 30, 2025 | 15.68 Mn |
| Mar 31, 2025 | 19.19 Mn |
| Dec 31, 2024 | 20.43 Mn |
| Sep 30, 2024 | 9.01 Mn |
| Jun 30, 2024 | 16.91 Mn |
| Mar 31, 2024 | 20.39 Mn |
| Dec 31, 2023 | 24.24 Mn |
| Sep 30, 2023 | 5.22 Mn |
| Jun 30, 2023 | 11.56 Mn |
| Mar 31, 2023 | 11.20 Mn |
| Dec 31, 2022 | 4.93 Mn |
| Sep 30, 2022 | 2.93 Mn |
| Jun 30, 2022 | 6.48 Mn |
| Mar 31, 2022 | 22.08 Mn |
| Dec 31, 2021 | 25.29 Mn |
| Sep 30, 2021 | 13.83 Mn |
| Jun 30, 2021 | 3.55 Mn |